Related Experiment Video
Updated: Jul 29, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Melianone inhibits Secreted Aspartic Proteases (SAP), a Virulence Factor During Hyphal Formation in Candida albicans
Amalanathan Veni1, T Sivaswamy Lokeswari1, Dhanapal Pavithra1,2
1Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai 600116, Tamil Nadu, India.
Background & Objective:
Candida albicans (C.-P. Robin) Berkhout, the pathogenic yeasts' ability to transform from yeast to hyphal forms in the bloodstream is essential during systemic infections. Among the several virulence factors studied, secreted aspartic proteinases (SAPs) involved in hyphal penetration are targets of putative hyphal inhibitors. Upregulation of SAP6 gene, (two-to 31- fold high) during budded to hyphal transition and lack of studies on its inhibition, prompted us to investigate this particular protein using in silico tools.
Results:
Hyphal inhibition of germinating yeast cells by melianone, a triterpenoid, from Swietenia mahagoni (L.) Jacq. (Meliaceae) was observed at 0.1 μM (IC50). One of the targets of putative hyphal inhibitors, SAP, was assayed and for the first time, 50 % of the biological SAP activity was found to be inhibited by melianone at 0.125 μM. This data on SAP inhibition led us to analyse the 3-dimensional structure for SAP6 protein that was constructed through a combination of homology modelling and ab-initio method (Phyre2) and validated before performing Induced Fit Docking (IFD). Melianone formed H-bond and hydrophobic interactions with the crucial residues (ASP108, TYR160, ALA161, ASP162, ASP294, THR297, ASP379) in the catalytic site of SAP6 with a glide energy (-)54.9327 kcal/mol upon Induced Fit Docking (IFD).
Conclusion:
We report here for the first time on the SAP inhibitory ability of melianone at 0.125 uM. Being a small molecular mass inhibitor, binding with high affinity to the S3 pocket sites of SAP proteins provides evidence for pre-clinical testing of such compounds against fungal pathogens. The study is a valuable insight for further research on novel and effective inhibitors targeting SAP.
Insights
Melianone inhibits Candida albicans secreted aspartic proteinase 6 (SAP6), a key virulence factor in systemic fungal infections. This study provides a basis for developing new antifungal treatments targeting SAP proteins.
Area of Science:
- Mycology
- Biochemistry
- Computational Biology
Background:
- Candida albicans's yeast-to-hyphal transition is crucial for systemic infections.
- Secreted aspartic proteinases (SAPs) are virulence factors involved in hyphal penetration.
- SAP6 is significantly upregulated during hyphal transition, yet its inhibition is understudied.
Purpose of the Study:
- To investigate the inhibitory potential of melianone against SAP6.
- To analyze the molecular interactions between melianone and SAP6 using in silico methods.
Main Methods:
- Melianone's hyphal inhibition and SAP inhibitory activity were assayed.
- The 3D structure of SAP6 was constructed using homology modeling and ab initio methods (Phyre2).
- Induced Fit Docking (IFD) was performed to analyze melianone-SAP6 interactions.
Main Results:
- Melianone inhibited hyphal growth at 0.1 μM (IC50) and 50% of SAP activity at 0.125 μM.
- IFD revealed melianone forms hydrogen bonds and hydrophobic interactions with key catalytic residues of SAP6.
- A glide energy of -54.9327 kcal/mol was observed for melianone binding to SAP6.
Conclusions:
- Melianone exhibits significant SAP inhibitory activity, marking the first report of its kind.
- Melianone's high affinity for SAP proteins suggests potential as a pre-clinical antifungal agent.
- This research offers valuable insights for developing novel inhibitors targeting SAP proteins in fungal pathogens.
Related Concept Videos
Amino Acid Catabolism
Gene Regulation in Microbial Communities: Quorum Sensing
Microbes and Methanogenesis
Determinants of Bacterial Pathogenicity and Virulence
Candidiasis
Antifungal Agents

